# BioIVT

BioIVT is an Asset Manager based in New York, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** New York, United States
- **Region:** North America
- **Address:** New York, NY, United States
- **Assets under management:** Undisclosed
- **Website:** bioivt.com
- **LinkedIn:** https://www.linkedin.com/company/bioivt

## Regulatory record

- **Reports private funds:** No

## About

BioIVT is a company founded in 1981 in Hicksville, New York. It specializes in providing biological specimens and services for precision medicine research. BioIVT offers control and disease state samples, including human and animal tissues, cell products, blood, and other biofluids, as well as hepatic modeling solutions and ADME-Tox model systems.

## Sectors

- Healthcare Services

## Questions

### What specific biological products does BioIVT supply?

BioIVT provides primary cells, tissue samples, blood products, and subcellular fractions from both human and animal sources. Key products include cryopreserved hepatocytes, tissue microarrays, and disease-state plasma. These materials are widely used in ADME toxicology, drug metabolism, and pharmacokinetic studies.

### What types of research studies use BioIVT's products?

BioIVT's specimens support preclinical drug discovery, biomarker validation, and in vitro diagnostic assay development. Researchers use its hepatocytes for metabolic stability profiling and its disease-state blood products for companion diagnostic calibration. The firm's materials are also used in cell-based potency assays required by regulatory submissions.

### Does BioIVT operate internationally?

Yes, BioIVT maintains donor programs, processing labs, and logistics hubs across North America and Europe. Its international footprint allows the firm to source diverse donor populations and deliver fresh samples to clients in multiple regions. This network was expanded in part through acquisitions of European biospecimen providers.

### How is BioIVT different from clinical trial logistics providers?

BioIVT focuses on pre-clinical and research-grade specimens rather than commercial drug distribution. While logistics providers move investigational drugs between trial sites, BioIVT supplies the actual biological starting material — cells, tissues, and plasma — that researchers use to test candidate molecules before human trials. Its value is in the quality and characterization of the specimen itself, not the distribution network.

## Related profiles

- [SACO Foods](https://altss.com/profile/saco-foods)
- [Wilsonart](https://altss.com/profile/wilsonart-llc)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/bioivt

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology